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Abstract
Background: To determine alignment of proposed international standard outcomes sets for ophthalmic conditions
to metrics currently reported by eye hospitals.
Methods: Mixed methods comparative benchmark study, including eight eye hospitals in Australia, India,
Singapore, Sweden, U.K., and U.S. All are major international tertiary care and training centers in ophthalmology.
Main outcome measure is consistency of ophthalmic outcomes measures reported.
Results: International agreed standard outcomes (ICHOM) sets are available for cataract surgery (10 metrics) and
macular degeneration (7 metrics). The eight hospitals reported 22 different metrics for cataract surgery and 2 for
macular degeneration, which showed only limited overlap with the proposed ICHOM metrics. None of the hospitals
reported patient reported visual functioning or vision-related quality of life outcomes measures (PROMs). Three
hospitals (38%) reported rates for uncomplicated cataract surgeries only. There was marked variation in how and at
what point postoperatively visual outcomes following cataract, cornea, glaucoma, strabismus and oculoplastics
procedures were reported. Seven (87.5%) measured post-operative infections and four (50%) measured 30 day
unplanned reoperation rates.
Conclusions: Outcomes reporting for ophthalmic conditions currently widely varies across hospitals internationally
and does not include patient-reported outcomes. Reaching consensus on measures and consistency in data
collection will allow meaningful comparisons and provide an evidence base enabling improved sharing of “best
practices” to improve eye care globally. Implementation of international standards is still a major challenge and
practice-based knowledge on measures should be one of the inputs of the international standardization process.
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Background
Outcome reporting is mandated in many health care
systems, and it is being incorporated into good
medical practice and physician maintenance of certifi-
cation [1, 2]. Several eye care providers and govern-
mental entities indeed publicly report performance,
often comparing outcomes with evidence-based
benchmarks or targets [3–8]. The objective of report-
ing outcomes of high volume, high risk, or high cost
procedures has been described as optimizing clinical
efficacy and patient safety as well as cost-effectiveness
[9–11].
Two leading subspecialties in ophthalmology recently
developed a global standard outcomes set with the
International Consortium of Outcomes Measurement
(ICHOM) framework. The first one was for cataract
[12, 13]. Cataract surgery, a removal of an opaque lens
and replacement with an artificial intraocular lens
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implantation, is the most frequently performed elective
surgical procedure in many countries, and rates of this
surgery are likely to continue increasing as access im-
proves in developing countries [14]. The second stand-
ard set was developed for macular degeneration, the
leading cause of irreversible vision loss, accounting for
over 15% of blindness in high-income countries, with
an expected increase of the burden of disease [15, 16].
The standards sets propose to track preoperative visual
acuity and target refraction, patient-reported visual
function, intraoperative complications including cap-
sule problems and dropped nucleus as well as other
postoperative complications.
However, cataract surgery, macular degeneration and
other subspecialties appear to currently have wide varia-
tions not only in outcome definition and risk stratifica-
tion but also in metrics currently publicly reported.
Collection of complete, reliable and robust outcome
measurements is challenging [17, 18] and public report-
ing of individual surgeon’s outcomes in other surgical
specialties, such as cardiac surgery, is not without
controversy [19–21]. It is important to carefully select
outcome measures and use unambiguous, consistent,
transparent methodologies, to ensure that data can be
reliably compared across institutions internationally [22].
Despite its effectiveness, rates of ophthalmic treatment
vary substantially between countries and the need for
systematic measurement of outcomes is paramount. One
would expect standardized outcomes measures to deliver
“value-based cataract care” as theoretically envisioned by
Michael Porter and others [23, 24]. In recent years, the
policy concept of value-based medicine, and a change in
focus from ‘volume’ to ‘value’, have been increasingly dis-
cussed within in various health care systems, resulting in
tracking of outcomes and changed reimbursement meth-
odologies. Moreover, increased attention to surgical
error, patient safety, and healthcare costs has increased
public interest in reporting and comparing clinical per-
formance. While the international standard sets are pre-
sented, little is known about the actual use of these
indicators in hospital practice and the metrics that are
currently used for other subspecialties.
In this paper, we map current ophthalmic outcome mea-
sures reported by a volunteer sample of major ophthalmic
hospitals, which aspire to be exemplars of ophthalmic in-
dicator use internationally to global standard sets, and
provide insights into useful metrics to assess performance
in ophthalmology and some of the challenges of imple-
menting such measures across institutions.
Methods
In this mixed methods descriptive study, we performed a
review of the outcomes reported and compared this to
existing standards [25]. Nine hospitals that are self-
declared leaders in the routine publication and use of
ophthalmic outcome indicators and that are members of
an international eye hospital association were invited to
participate in the study. The hospitals are participating
in existing operational benchmarking initiatives that
have been reported before [8, 26] and hence functioned
as a convenient sample for the current review study on
outcomes. Eight hospitals agreed on participation, and
appointed one main point of contact that provided in-
side information on the availability and use of indicators
in the respective hospitals. The websites of the eight
hospitals were reviewed for publicly reported outcomes
data or metrics on ophthalmic outcomes. Five institu-
tions were found to have published data available on
their website (Cole Eye Institute at Cleveland Clinic,
University of Michigan W.K. Kellogg Eye Center,
Massachusetts Eye and Ear Infirmary, Moorfields Eye
Hospital, and Singapore National Eye Center). We
searched the Medline, Cochrane, Emerald, Web of
knowledge and Web of Science databases to find exist-
ing outcomes benchmark data using the following terms:
ophthalmology, cataract, macular degeneration, out-
comes, metrics, measures, and benchmarks. Preferred
Practice Patterns from the American Academy of Oph-
thalmology (AAO), Clinical Guidelines from the Royal
College of Ophthalmologists (RCOphth), and cited tar-
gets or benchmarks that each hospital had used were
reviewed. In addition to the outcomes data published on
the hospitals’ websites, non-published measures (eg, an-
nual reports, departmental quality reports, auditing re-
ports) were recorded through the main point of contact
in the respective hospitals. Outcomes were added from
Aravind Eye Hospital (Madurai, India), Moorfields Eye
Hospital (London, United Kingdom), Singapore National
Eye Center, The Royal Victorian Eye and Ear Hospital
(Melbourne, Australia) and St. Erik’s Eye Hospital
(Stockholm, Sweden). For the purposes of this paper,
and to facilitate the sharing of non-publicly reported
data, the hospital names were anonymized when com-
paring quality performance measures. University of
Michigan’s and each of the participating hospitals’ Insti-
tutional Review Boards approvals were waived for this
quality of care study.
Results
Data from eight institutions were available and were
grouped according to outcomes measures recommended
in the international standard sets.
Cataract surgery
Outcomes for cataract surgery are listed in Table 1,
following the recommended classification of intraopera-
tive and postoperative measures. Preoperative demo-
graphics, baseline visual status, ocular comorbidities and
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prior ophthalmic interventions are not listed. The eight
hospitals reported a total of 22 different metrics for cata-
ract surgery outcomes. None of the hospitals reported
patient reported visual functioning. Three hospitals re-
ported rates for uncomplicated cataract surgeries only.
Six (75%) hospitals reported postoperative visual acuity,
of which five (62.5%) reported postoperative outcomes
of best-corrected visual acuity ≥ 20/40. There was
marked variation in how and at what point postopera-
tively visual outcomes following cataract surgery were
reported. Five (62.5%) reported the difference in refrac-
tion from the preoperative biometry based target. Seven
(87.5%) measured post-operative infections and four
(50%) measured 30 day unplanned reoperation rates.
Seven institutions (87.5%) assessed visual acuity, and the
most common outcome benchmark reported was best-
corrected visual acuity of 20/40 or better. The most
common refractive outcome measured was spherical
equivalent within 1 diopter (D) of target refraction. With
regard to postoperative complications, none of the hos-
pitals reported on persistent corneal edema while only
less then half of the hospitals reported other
complications.
Macular degeneration
Outcomes for macular degeneration are presented in
Table 2, following the order of the standard set visual
functioning and vision-related quality of life, disutility of
care and disease control. Two hospitals (25%) reported on
visual acuity. None of the hospitals reported on mobility
and independence, emotional well-being or reading and
accessing information. For complications of treatment, the
most common measure was endophthalmitis rate follow-
ing intravitreal injection, presented by five hospitals
(62.5%). None of the hospitals reported the presence of
intraretinal or subretinal fluid or hemorrhage.
Other outcomes
The outcomes of the other ophthalmic procedures re-
ported by the hospitals are presented as Supplementary
Data. Refractive surgery outcomes are presented in
Additional file 1. Several hospitals report refractive out-
comes in detail, which is useful for marketing purposes
to potential customers/consumers for such procedures.
However, there are many permutations and combina-
tions of refractive treatments and preoperative refractive
errors precluding easy comparison. Medical and surgical
Table 1 Comparison of ICHOM outcome measures for cataract surgery and reported measures in study hospitals
Item Proposed ICHOM
Measure
Reported Measure
in Study Hospitals
Number of Hospitals
Reporting
Reported Value
Intraoperative Complications Capsule problems Posterior capsule rupture 6/8 0.64–2.11%
Dropped nucleus or lens
fragment into vitreous
Retained lens matter 1/8 0.21%
Other Intraoperative complications 1/8 1.87%
Zonular dialysis 1/8 0.11%
Choroidal hemorrhage 1/8 0.11%
Postoperative Visual acuity Post-operative visual acuity BCVA 20/40 or better at 4–6 weeks,
all cases
2/8 91%
BCVA 20/40 or better at 4–6 weeks,
excluding co pathology
3/8 87–100%
1–14 letters improvement ETDRS
VA score
1/8 ≈ 52%
≥ 15 letters improvement ETDRS
VA score
1/8 ≈ 42%
Refractive error Post-operative refractive error Final spherical equivalent within
1 D of target
5/8 85–97%
Patient-reported
visual function
Rasch-calibrated score from
Catquest 9SF or other
Rasch-calibrated PROM
NA 0/8 NA
Complications Return to operating theater Unplanned reoperation within
30 days of surgery
4/8 1.1–1.52%
Endophthalmitis rate Endophthalmitis rate 6/8 0.0–0.07%
Persistent corneal edema NA 0/8 NA
Other (any postoperative
complication within 3 months
requiring treatment or
compromising outcome)
Postoperative complications 1/8 0.36%
Unplanned vitrectomy 4/8 0.48–1.93%
Iris trauma 1/8 0.32%
ETDRS Early Treatment Diabetic Retinopathy Study, BCVA best corrected visual acuity, D Diopter, VA visual acuity
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retina outcome measures other than related to macular
degeneration are shown in Additional file 2. Some insti-
tutions risk-stratify surgical retina outcomes by initial
surgery or reoperations, while others subdivide cases by
specific etiology. Metrics include both functional (visual
acuity) and structural (retinal re-attachment rate) out-
comes. There is variation in reported outcome measures
for pediatric and strabismus surgery, Additional file 3.
Some hospitals measure complications or reoperation
rates. There are also two hospitals that measure the
postoperative improvement in ocular alignment, with
success being defined as less than 10–15 prism diopter
of residual eso- or exotropia. Additional file 4 demon-
strates glaucoma and corneal surgery outcome measures.
The cornea outcomes primarily focus on corneal trans-
plant failure or rejection rate. The expected failure rate
differs significantly based on which type of corneal graft,
and some institutions differentiate their results based on
corneal procedure type. Some hospitals report post-
operative visual acuity or improvement following corneal
transplant surgery. All institutions measure either intra-
operative or postoperative complications with some
reporting glaucoma surgery ‘failure’ or ‘success’ rates
and/or post-operative endophthalmitis rates. The latter
is presumed to be early surgery-related endophthalmitis,
with little information regarding late blebitis related
cases. Two institutions set a goal for intraocular pressure
(IOP) of < 17 mmHg or < 21 mmHg and one institution
looked at only the change in IOP following surgery.
Interestingly, data is not published on the use of anti-
metabolites (including the re-needling rates with/with-
out antimetabolites) and whether surgery is combined
with cataract. Oculoplastics outcome measures are
shown in Additional file 5. Some departments measure
reoperation rates or complication rates. Two hospitals
measure postoperative ptosis repair success – one based
on postoperative eyelid symmetry and the other looks at
patient satisfaction rates on a scale of 1–10.
Discussion
We present the first review of ophthalmic outcome mea-
sures reported by eye hospitals in diverse populations in
various nations. The study is limited by the number of
institutions who publicly report outcomes and indica-
tors, and a reluctance from a number of institutions to
either devote resource to gather regular indicator results
to benchmark or, if gathered, to share or publish indica-
tor results. This rendered a comprehensive or global
data gathering study impractical at this time, but the use
of a sample of leading institutions was possible and,
Table 2 Comparison of ICHOM outcome measures for macular degeneration and reported measures in study hospitals
Item Propose ICHOM Measure Reported measure
in study hospitals
Number of
hospitals reporting
Target Reported
value
Visual functioning
and vison-related
quality of life
Distance
visual acuity
Distance visual acuity
(best of uncorrected,
corrected, or pinhole) in
the affected eye.
Gain VA (15 ETDRS letters)
after injections for macular
degeneration
1/8 > 20% 20.7%
Visual stability
(loss < 15 ETDRS letters)
after injections for
macular degeneration
1/8 > 80% 90.25%
Mobility and
independence
Impact of vision impairment
questionnaire
NA 0/8 None NA
Emotional
well-being
Impact of vision impairment
questionnaire
NA 0/8 None NA
Reading and
accessing
information
Impact of vision impairment
questionnaire
NA 0/8 None NA
Disutility of care Number of
treatments
Documentation of individual
treatments received for
macular degeneration
Appointment access and
check in (% best response)
1/8 None ≈ 63%
Clinic wait times and
comfort (% best response)
1/8 None ≈ 45%
Complications of
treatment
Endophthalmitis: severe
intraocular inflammation
within 3 months of last
intraocular treatment
Endophthalmitis after
anti-VEGF intravitreal
injections
5/8 None or
0.2–1.9%a
0.05%
(MARINA)
0–0.18%
Disease control Presence of
fluid, edema,
or hemorrhage
Presence of intraretinal or
subretinal fluid or hemorrhage
that is attributable to activity
of the neovascular lesion
NA 0/8 None NA
ETDRS Early Treatment Diabetic Retinopathy Study, RD retinal detachment, VEGF vascular endothelial growth factor, PVR proliferative vitreo-retinopathy
aBhavsar et al. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required. Arch Ophthalmol 2009; 127(12): 1581–1583
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although by necessity only permitting descriptive statis-
tics, does demonstrate both the utility and the issues in
attempting to use ophthalmic indicators to benchmark
and compare performance across institutions and coun-
tries. Although several hospitals report similar outcomes
and targets or benchmarks in each subspecialty, there is
little congruence on which outcomes or benchmarks
should be reported, which methodologies should be used
and how to address preoperative risk and co-morbidity.
Despite the existence of two internationally agreed
ICHOM standards for eye care, compliance with the
proposed measures is limited and especially measure-
ment of recommended patient reported visual function-
ing or vision-related quality of life outcomes measures
(PROM’s) is not yet taking place systematically. While
we realize that health care systems are complex and
(large) differences between health systems could be bar-
rier for valid comparisons, [8] other surgical specialties
have long recorded outcomes and such reporting has
improved clinical and cost effectiveness as well as pa-
tient safety [19, 27]. Initial fears of surgeon avoidance of
high-risk cases or unfair reputational damage have
proved largely unfounded [19]. In the U.K. many surgical
specialties publish their outcomes, and in 2016 the first
pilot with a national reporting on cataract surgery out-
comes was done in a similar fashion [28]. Pay for per-
formance tools have been instituted by Medicare in the
US. The Physician Quality Reporting System (PQRS)
was initially started as an incentive system to promote
quality of care and outcome reporting. In 2017, ophthal-
mic practices who do not report three quality measures
50% of time will receive a 2 % penalty on Medicare re-
imbursements 2 years down the road. Physicians who re-
port nine measures in three of the new national quality
strategy domains will receive a 0.5% bonus payment
[29]. With the increasing prevalence of electronic record
systems, quality-focused healthcare, rising patient expec-
tations as well as increasing cost pressures, our expect-
ation is that outcome reporting in ophthalmology will
globally become the norm instead of the exception.
Goals in clinical outcome reporting include encouraging
quality improvement, creating a minimum standard for
providers, driving innovation in care, performance man-
agement of units and individual surgeons, distributing pay
incentives, increasing informed decision making for pa-
tients as well as promoting public confidence in healthcare
providers, and contributing to research [30, 31]. Reporting
outcomes data to the public may promote greater scrutiny
of health care and reduce variations in the quality of care,
thereby making physicians more accountable [32].
One potentially straightforward method of outcome
reporting is to indicate ophthalmic quality and safety by
measurement of the rate of serious adverse healthcare
associated events such as postoperative infections,
unplanned reoperations, and so called ‘never events’.
‘Never events’ are serious, potentially preventable errors
in healthcare, for example in cataract care these may in-
clude operating on the wrong patient, on the wrong eye,
or inserting the incorrect (unplanned) intraocular lens
[33]. ‘Never events’ are taken seriously and investigated
with root cause analysis, and actions should be taken to
prevent error recurring with a culture of fair blame.
There was significant consensus in this area, with all in-
stitutions reporting similar values; however some institu-
tions reported only subspecialty-specific data.
In cataract surgery, many institutions report visual
acuity – the most common target was best-corrected
visual acuity of 20/40 or better, however another strategy
is to consider improvement in visual acuity. We found
that timing of follow-up for outcome reporting following
cataract surgery may be influenced by particular health
system or hospital’s practice patterns. For example if
post-operative cataract patients are discharged from
ophthalmic care or followed up in the community the
return of outcome data may be problematic.
It is notable that there is a lack of hospitals using
patient-reported measures, while patient satisfaction and
experience rates are commonly used measure by payers
and state agencies. In contrast, while a variety of instru-
ments have been employed in research studies for asses-
sing the impacts of cataract (and other ocular) surgery
on patients’ symptoms, functional ability, wellbeing and
health, these are not yet generally publicly reported in
clinical care. These PROM’s can be divided into generic
assessments that have been designed to apply across a
range of different health conditions (for example, the
EuroQol EQ-5D and SF-36) and instruments that focus
specifically on vision-related conditions (for example,
the VF-14). Properly developed PROM’s are valid and re-
liable research tools but they can be cumbersome for pa-
tients to use routinely on a large-scale basis [34]. The
RCOphth resisted the use of the VF-14 PROM metrics
for routine use in the U.K. National Health Services
(NHS) cataract surgery for referral or reimbursement
purposes, as the College was of the opinion that it added
no value in routine NHS care in the U.K. [1]. Subse-
quent research confirmed the College’s concerns about
the VF-14 tool [35, 36]. PROM’s tools are increasingly
being tied to reimbursement and their use is likely to be
an area of growth in ophthalmic care the future.
Limitations of current ophthalmic indicator use
As electronic records become standardized and more pa-
tient specific data is readily available, ophthalmic outcome
measures will become easier to obtain and potentially more
meaningful. The merit of quality reporting depends on data
quality, risk adjustment, sample size, and the specification
of quality measures themselves [37]. Current ophthalmic
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outcomes reporting methods do not usually take into ac-
count the complicated statistical methods for risk adjust-
ment used in other healthcare fields and hence we have not
applied any quantitative comparison or statistical tests in
this study. The issue of case mix adjustments is a critical
topic in other specialties that publicly report outcomes.
Failure to adjust for such may discourage surgeons from
treating high-risk patients and therefore deny high-risk
patients the opportunity of benefiting from surgery, while
appropriate risk adjustment can do much to allay these
concerns. There has been reported reluctance of some car-
diac surgeons to operate on high-risk patients for these rea-
sons [38, 39] and, without appropriate risk adjustment,
unintended distortions of appropriate surgical care may
thus arise to the ultimate detriment of the public [40].
At present, hierarchical regression is the gold standard
for risk adjustment of outcomes and for producing pro-
vider report cards; however this gold standard is rarely
used [41] and no equivalent modeling has been devel-
oped in ophthalmology to date. The National Ophthal-
mic Database (NOD) in the U.K. has compiled a
national cataract data set, and participating cataract sur-
geons have the ability to compare their individual surgi-
cal data to others in a risk-adjusted manner [28]. A new
American registry [42] may have the ability to risk strat-
ify eye surgeons’ case mix, while previous groups have
either excluded any patients with comorbidities or not
performed case mix analysis.
Next steps
Increasingly, there are national and multi-national col-
laborations that are collecting large quantities of data on
structures, processes, and outcomes of care, and this is
facilitated by increasing use of electronic health records
which removes many previous barriers to large scale
data gathering. These databases will become more
prominent and powerful with their ability to retrieve
data directly from electronic medical records.
The European Registry of Quality Outcomes for
Cataract and Refractive Surgery (EUREQUO) was initi-
ated in 2008 by 11 European countries to improve treat-
ment and standards of care for cataract and refractive
surgery and to develop evidence based guidelines [43].
As of mid-2016, more than 2 million cataract operations
were included in the database and specific guidelines
were established regarding cataract surgery. These
guidelines, in addition to the benchmark set by Hahn
and colleagues [44] for cataract surgery, may be useful
benchmarks for other organizations to use.
The Intelligent Research in Sight (IRIS) registry is a clin-
ical data registry designed by the American Academy of
Ophthalmology (AAO) that opened to all AAO member
physicians since 2014. This registry automatically collects
data from participating electronic health record systems
and provide benchmark reports for participating practi-
tioners. As of 1 January 2016, the IRIS registry included
11,739 physicians, and registered 72.05 million visits
representing 20.5 million patients presumably [45, 46].
Finally, ICHOM’s standard guideline sets for cataract
surgery [13] and macular degeneration [15] have been
rigorously developed with the goal of improving quality of
health care, reducing health care costs, and supporting in-
formed decision-making. As the currently reported out-
comes were found to be only partially in line with the
standards, in some instances the ICHOM sets might need
to shift to align with what is currently done. In most in-
stances, however, institutions might opt to align their
reporting with the standard sets, which is the direction the
institutions participating in our study are currently taking.
Our study shows that much more alignment on the
concept of value based eye care will be needed to imple-
ment the standards in the day-to-day hospital practice and
gives suggestions for future metrics in other subspecialties
to be developed. Practice-based knowledge on outcome
measures, as provided in this paper, should form part of
the input of the international standardization process to
assure implementation.
Conclusion
Outcomes reporting for ophthalmic surgery currently
widely varies across hospitals globally, and value too
often seems to be defined in the eyes of the beholder.
Reaching consensus on outcomes measures will allow
meaningful comparisons of outcomes at different hospi-
tals which will provide an evidence base enabling im-
proved sharing of “best practices” to improve eye care
globally. Identifying standardized and common metrics
is an important first step to improve the quality of out-
come data. As data improves and methods of risk adjust-
ment become more mature, outcome metrics can help
institutions to improve the quality of the patient care
they provide and demonstrate this quality to patients,
payers of healthcare and regulators. However, setting of
international standards on outcomes should include
practice-based knowledge, as provided through the map-
ping exercise in this paper, from the beginning.
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